Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Cisatracurium Besylate NDC 71288-714 by Meitheal Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
cis05 0003 01
cis05 0003 02
cis05 0003 03
cis05 0003 04
cis05 0003 05
Cisatracurium Besylate Injection is a paralyzing agent intended only for use in the ICU setting via intravenous injection. It is available in a 20 mL single-dose vial containing 10 mg/mL and must be stored at 2-8°C (36-46°F) and protected from light. Once removed from refrigeration and brought to room temperature, it must be used within 21 days, even if re-refrigerated. Cisatracurium Besylate Injection can cause respiratory arrest and facilities using it must have measures in place for immediate artificial respiration. This product is manufactured for Meitheal Pharmaceuticals in Chicago.*
cis05 0003 06
cis05 0003 07
cis05 0003 08
cis05 0003 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.